Revenue | ₹23.12Cr |
Net Profits | ₹1.65Cr |
Net Profit Margins | 7.14% |
Par Drugs & Chemicals Ltd’s revenue jumped 1.54% since last year same period to ₹23.12Cr in the Q4 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 6.79% jump in its revenue since last 3-months.
Par Drugs & Chemicals Ltd’s net profit fell -55.65% since last year same period to ₹1.65Cr in the Q4 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 184.48% jump in its net profits since last 3-months.
Par Drugs & Chemicals Ltd’s net profit margin fell -56.32% since last year same period to 7.14% in the Q4 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 166.39% jump in its net profit margins since last 3-months.
The revenue for Par Drugs & Chemicals Ltd in the Q4 results 2024 was ₹23.12Cr.
The net profit for Par Drugs & Chemicals Ltd in the Q4 results 2024 was ₹1.65Cr.
The net profit margin for Par Drugs & Chemicals Ltd in the Q4 results 2024 was 7.14%.
The revenue for Par Drugs & Chemicals Ltd in the Q4 results 2023 was ₹22.77Cr.
The net profit for Par Drugs & Chemicals Ltd in the Q4 results 2023 was ₹3.72Cr.
The net profit margin for Par Drugs & Chemicals Ltd in the Q4 results 2023 was 16.34%.